As of February 2026, the two biotech pioneers synonymous with the mRNA-based COVID-19 vaccine rollout, Moderna and BioNTech, face a...

Investors in Truist Financial are shifting their focus toward shareholder returns as the company enters a period of consolidation following...

The market is applying fresh pressure to Microsoft's equity as investors recalibrate their expectations around the company's aggressive artificial intelligence...

India Globalization Capital (IGC Pharma) is significantly expanding the clinical development of its Alzheimer's drug candidate, IGC-AD1. The company has...

The Glimpse Group is poised to release its second fiscal quarter results, a report that will be closely scrutinized for...

The spotlight returns to tobacco giant Altria next week, as its leadership prepares to address investors at a major industry...

Market participants are turning their attention to US Global Investors as the investment firm prepares to release its second-quarter financial...

A significant leadership appointment signals a more aggressive phase for Advanced Micro Devices (AMD) as it seeks to capitalize on...

A significant leadership transition is underway at Diginex, signaling a strategic consolidation of its recent acquisitions. The company has appointed...

The publicly traded chapter for CureVac has officially closed. The mRNA specialist's shares have ceased trading on public exchanges after...